SINCO PHARMA(06833),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

06833 SINCO PHARMA

Not Yet Opened 04-29 09:00:06

0.189

+0.000

0.00%

High0.189	Low0.189	Vol0.00
Open0.189	D1 Closing0.189	Amplitude0.00%
Mkt Cap384.24M	Tradable Cap384.22M	Total Shares2.03B
T/O0.00	T/O Rate0.00%	Tradable Shares2.03B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"06833","market":"HK","secType":"STK","nameCN":"SINCO PHARMA","latestPrice":0.189,"timestamp":1777424406064,"preClose":0.189,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":2032890585,"shares":2032999999,"eps":0.019458585747760597,"marketStatus":"Not Yet Opened","change":0,"latestTime":"04-29 09:00:06","open":0.189,"high":0.189,"low":0.189,"amount":0,"amplitude":0,"askPrice":0.191,"askSize":100000,"bidPrice":0.185,"bidSize":8000,"shortable":0,"etf":0,"ttmEps":0.019458585747760597,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1777512600000},"marketStatusCode":0,"adr":0,"listingDate":1457539200000,"exchange":"SEHK","adjPreClose":0.189,"dividendRate":0.010582,"openAndCloseTimeList":[[1777426200000,1777435200000],[1777438800000,1777449600000]],"volumeRatio":0,"lotSize":4000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06833/tweets","defaultTab":"tweets","newsList":[{"id":"1168699838","title":"SINCO PHARMA Publishes 2025 Annual Report and AGM Documents, Reinforces E-Communication Policy","url":"https://stock-news.laohu8.com/highlight/detail?id=1168699838","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168699838?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:43","pubTimestamp":1776685391,"startTime":"0","endTime":"0","summary":"On 21 April 2026, Sinco Pharmaceuticals Holdings Limited (SINCO PHARMA) announced that its 2025 Annual Report, accompanying circular and Notice of Annual General Meeting have been released in both...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125134289","title":"Sinco Pharma Publishes 2025 Annual Report and AGM Papers, Accelerates Switch to Full Electronic Communications","url":"https://stock-news.laohu8.com/highlight/detail?id=1125134289","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125134289?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:43","pubTimestamp":1776685381,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals Holdings Limited announced on 21 April 2026 that its 2025 Annual Report, accompanying circular, notice of Annual General Meeting and proxy form are now available in both English...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121220588","title":"Sinco Pharma Proposes 20% Issuance Mandate, 10% Share Buyback and HK$3.40 Million Final Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1121220588","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121220588?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:23","pubTimestamp":1776684210,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals Holdings Limited (“Sinco Pharma”) has issued a circular convening its Annual General Meeting (AGM) for 15 May 2026 in Chengdu, where shareholders will vote on four key items: 1....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152637237","title":"SINCO PHARMA Sets 15 May 2026 AGM; Seeks Approval for HK$3.40 Million Final Dividend, Board Mandates and Auditor Re-appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=1152637237","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152637237?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:23","pubTimestamp":1776684183,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals Holdings Limited (SINCO PHARMA, 06833) has issued a notice convening its 2026 Annual General Meeting (AGM) for 10:00 a.m. on 15 May 2026 at Room E5-1805, New Century Global...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628424747","title":"Sinco Pharmaceuticals announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2628424747","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628424747?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:12","pubTimestamp":1776683579,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals Holdings will hold annual general meeting in Chengdu, China on May 15, 2026.Shareholders will vote on adopting audited consolidated financial statements for FY2025.Meeting will consider re-election of independent non-executive directors Wang Qing, Bai Zhizhong, Lau Ying Kit.Agenda includes re-appointment of Rongcheng  CPA as auditor.Shareholders will vote on final dividend of HKD 0.167 cents per share, totaling HKD 3.4 million, plus share issuance and buyback mandates.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinco Pharmaceuticals Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 20, 2026,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL18gTFd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123609766","title":"SINCO PHARMA 2025年年报要点：营收降至人民币20.846亿元，核心业务聚焦生物制剂与医美板块","url":"https://stock-news.laohu8.com/highlight/detail?id=1123609766","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123609766?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:06","pubTimestamp":1776683181,"startTime":"0","endTime":"0","summary":"SINCO PHARMA于2025年实现营收人民币20.846亿元，较上年同期下降26.1%，其中核心收入主要来自人血白蛋白制剂。公司净利润为人民币0.3485亿元，同比减少约17.1%。年内毛利率从10.6%微升至10.7%，在销售下滑背景下展现一定成本管控成效。每股基本及摊薄盈利为人民币0.017元，董事会建议派发每股港币0.167元的末期股息。...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127794169","title":"Sinco Pharma’s 2025 ESG Report Shows Smaller Carbon Footprint, Higher Training Coverage and Zero Compliance Breaches","url":"https://stock-news.laohu8.com/highlight/detail?id=1127794169","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127794169?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:05","pubTimestamp":1776683102,"startTime":"0","endTime":"0","summary":"Sinco Pharma released its 2025 Environmental, Social and Governance (ESG) Report, outlining measurable progress on emissions, waste, employee development and governance. The company cut Scope 2...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628033744","title":"Sinco Pharmaceuticals releases 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2628033744","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628033744?lang=en_us&edition=fundamental","pubTime":"2026-04-20 18:58","pubTimestamp":1776682705,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals released its 2025 ESG report, outlining a board-led governance framework that integrates ESG factors into risk management.Scope 2 greenhouse-gas emissions from purchased electricity fell to 454.24 tonnes CO2e from 782.45 tonnes CO2e.Total electricity consumption rose to 1,837,528 kWh from 1,488,397 kWh, driven by start-up of Chengdu cold-chain warehouse operations.Scope 1 emissions increased, with road-transport fuel emissions at 39.07 tonnes CO2e from 34.33 tonnes CO2e.Water consumption climbed to 8,664 m3 from 7,891 m3, linked to aseptic simulation trials that lifted water demand.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinco Pharmaceuticals Holdings Ltd. published the original content used to generate th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL8kKmhG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628744206","title":"Sinco Pharmaceuticals publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2628744206","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628744206?lang=en_us&edition=fundamental","pubTime":"2026-04-20 18:51","pubTimestamp":1776682309,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals annual report for year ended Dec. 31, 2025 flagged weaker demand and sharper price pressure in China blood-products market, weighing on human albumin solution sales.Group shifted commercial focus toward deeper hospital coverage, with increased participation in volume-based procurement and alliance tenders to defend market position.Medical aesthetics pipeline advanced, with Girl Needle clinical summary completed and launch registration filed with National Medical Products Administration in Dec. 2025.Cold-chain and supply-chain platform in Chengdu continued full operation, with management targeting scale-up and efficiency gains via digital supply-chain upgrades.Board proposed final dividend of HKD 3.4 million, or HK 0.167 cents per share, subject to shareholder approval.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL5VDh5P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157928665","title":"SINCO PHARMA (06833) Announces Annual Results: Profit Attributable to Owners Declines 16.9% to RMB 34.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1157928665","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157928665?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:50","pubTimestamp":1774533017,"startTime":"0","endTime":"0","summary":"SINCO PHARMA (06833) has released its annual financial results for the period ending December 31, 2025. The Group reported revenue of RMB 2.085 billion, representing a decrease of 26.1% compared to...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142511745","title":"Sinco Pharma 2025 Results: Revenue Slides 26%, Net Profit Down 16.9% Amid Lower Albumin Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=1142511745","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142511745?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:44","pubTimestamp":1774532685,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals Holdings Limited (Sinco Pharma) reported full-year 2025 revenue of RMB 2.08 billion, a year-on-year decline of 26.10% or RMB 736.70 million, driven mainly by a reduction of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187480454","title":"Sinco Pharma Declares HK$0.167 Final Dividend for FY2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1187480454","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187480454?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:44","pubTimestamp":1774532663,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals Holdings Limited announced on 26 March 2026 a final ordinary dividend of HK$0.167 per share for the financial year ended 31 December 2025, subject to shareholder approval at the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622863753","title":"Sinco Pharmaceuticals FY2025 net profit drops 16.9% to RMB34.9 million; revenue falls 26.1% to RMB2.1 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2622863753","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622863753?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:38","pubTimestamp":1774532296,"startTime":"0","endTime":"0","summary":"Sinco published an annual results announcement reporting revenue of RMB2.08 billion, down 26.1%, mainly due to lower sales volume of human albumin solution.Gross profit fell 25.9% to RMB222.09 million, while gross margin was 10.7%, up 0.1 percentage point.Profit attributable to owners declined 16.9% to RMB34.85 million, and basic and diluted EPS was RMB0.017.Finance costs rose to RMB33.94 million, driven mainly by a RMB12.99 million guarantee fee paid to chairman Huang and higher interest and letter-of-credit charges.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinco Pharmaceuticals Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Ex","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL85fN1s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622486375","title":"Sinco Pharmaceuticals FY2025 final dividend is proposed at HKD 0.167 per share; payment date is set for June 4, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2622486375","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622486375?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:38","pubTimestamp":1774532291,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals proposed a final ordinary dividend of HKD 0.17 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinco Pharmaceuticals Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL66xGmW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123263759","title":"Sinco Pharma (06833) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=1123263759","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123263759?lang=en_us&edition=fundamental","pubTime":"2026-03-16 16:41","pubTimestamp":1773650468,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals Holdings Limited (Sinco Pharma, 06833) has scheduled a board meeting for Thursday, 26 March 2026 in Sichuan, PRC. The agenda includes: 1. Reviewing and approving the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619453987","title":"Sinco Pharmaceuticals schedules board meeting to approve annual results and consider final dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2619453987","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619453987?lang=en_us&edition=fundamental","pubTime":"2026-03-16 16:34","pubTimestamp":1773650062,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals will hold a board meeting on 26 March 2026 to consider and approve the group’s annual results for the year ended 31 December 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinco Pharmaceuticals Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL3q6qw8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193824649","title":"Sinco Pharmaceuticals (06833) Maintains 2.03 Billion Issued Shares in February 2026 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1193824649","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193824649?lang=en_us&edition=fundamental","pubTime":"2026-03-02 16:47","pubTimestamp":1772441242,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals Holdings Limited (06833) submitted its monthly return for the period ended 28 February 2026. The authorized share capital remained at 10,000,000,000 ordinary shares, each with a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139291131","title":"Sinco Pharmaceuticals (06833) Publishes January 2026 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1139291131","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139291131?lang=en_us&edition=fundamental","pubTime":"2026-02-02 20:03","pubTimestamp":1770033837,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals Holdings Limited (stock code: 06833) published its Monthly Return for the period ended 31 January 2026, confirming that its authorized share capital remained at 10,000,000,000...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603627877","title":"Investors Don't See Light At End Of Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Tunnel","url":"https://stock-news.laohu8.com/highlight/detail?id=2603627877","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603627877?lang=en_us&edition=fundamental","pubTime":"2026-01-15 08:54","pubTimestamp":1768438473,"startTime":"0","endTime":"0","summary":"With a price-to-earnings (or \"P/E\") ratio of 6.8x Sinco Pharmaceuticals Holdings Limited ( HKG:6833 ) may be sending...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-6833/sinco-pharmaceuticals-holdings-shares/news/investors-dont-see-light-at-end-of-sinco-pharmaceuticals-hol","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-6833/sinco-pharmaceuticals-holdings-shares/news/investors-dont-see-light-at-end-of-sinco-pharmaceuticals-hol","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1197","ISBC","BK4211","06833"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589386432","title":"Sinco Pharma Says Internal-Control Gaps Remedied After Review; Shares Slip 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589386432","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589386432?lang=en_us&edition=fundamental","pubTime":"2025-12-08 12:45","pubTimestamp":1765169102,"startTime":"0","endTime":"0","summary":"Sinco Pharmaceuticals  said it has completed remediation measures addressing deficiencies identified in an internal control review tied to a 2021 interest-free loan, according to a Dec. 05 Hong Kong bourse filing.Shares of the firm were down over 4% in Monday's midday trade.The company implemented revised connected-transaction procedures, strengthened fund management and payment approval policies, introduced petty cash controls, updated contract management steps, and formalised bank-account handling requirements.A follow-up review submitted concluded that the measures adequately address the previously identified gaps, according to the filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06833","BK1197"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinco-pharm.com","stockEarnings":[{"period":"1week","weight":0.0559},{"period":"1month","weight":0.0053},{"period":"3month","weight":0.05},{"period":"6month","weight":0.0053},{"period":"1year","weight":0.0161},{"period":"ytd","weight":0.0678}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.055},{"period":"3month","weight":-0.0664},{"period":"6month","weight":0.0079},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.0188}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Sinco Pharmaceuticals Holdings Ltd is an investment holding company primarily engaged in the provision of comprehensive marketing, promotion and channel management service for imported pharmaceutical products and medical devices. The Company operates three segments. The Sale of Imported Pharmaceutical Products segment engages in marketing, promotion, channel management activities for the sale of improved human plasma-based pharmaceuticals, antibiotics and other pharmaceuticals focused on therapeutic areas and complementary to human plasma-based products and other categories. The Research and Manufacturing of Aesthetic Medicine segment engages in the research and development and manufacturing of aesthetic medicine. The Medical Beauty Services segment engages in the provision of medical beauty services through its subsidiary company. The Company conducts its business in the domestic market.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.039713},{"month":2,"riseRate":0.5,"avgChangeRate":0.108153},{"month":3,"riseRate":0.5,"avgChangeRate":0.034834},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.079341},{"month":5,"riseRate":0.3,"avgChangeRate":-0.048869},{"month":6,"riseRate":0.2,"avgChangeRate":-0.079997},{"month":7,"riseRate":0.5,"avgChangeRate":0.07039},{"month":8,"riseRate":0.2,"avgChangeRate":-0.173894},{"month":9,"riseRate":0.4,"avgChangeRate":-0.015219},{"month":10,"riseRate":0.6,"avgChangeRate":0.146368},{"month":11,"riseRate":0.4,"avgChangeRate":0.058607},{"month":12,"riseRate":0.7,"avgChangeRate":0.063452}],"exchange":"SEHK","name":"SINCO PHARMA","nameEN":"SINCO PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SINCO PHARMA(06833),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SINCO PHARMA(06833) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SINCO PHARMA,06833,SINCO PHARMA股票,SINCO PHARMA股票老虎,SINCO PHARMA股票老虎国际,SINCO PHARMA行情,SINCO PHARMA股票行情,SINCO PHARMA股价,SINCO PHARMA股市,SINCO PHARMA股票价格,SINCO PHARMA股票交易,SINCO PHARMA股票购买,SINCO PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SINCO PHARMA(06833),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SINCO PHARMA(06833) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}